145 related articles for article (PubMed ID: 22461186)
1. Serum levels of selected chemokines in systemic lupus erythematosus patients.
Hrycek E; Franek A; Błaszczak E; Dworak J; Hrycek A
Rheumatol Int; 2013 Sep; 33(9):2423-7. PubMed ID: 22461186
[TBL] [Abstract][Full Text] [Related]
2. [Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].
Kopczyńska M; Franek A; Błaszczak E; Dworak J; Kopczyński P; Hrycek A
Pol Merkur Lekarski; 2013 May; 34(203):251-4. PubMed ID: 23894774
[TBL] [Abstract][Full Text] [Related]
3. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Tam LS; Li EK; Lam CW
Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
[TBL] [Abstract][Full Text] [Related]
4. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
5. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
6. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW; Petri M; Batliwalla FM; Koeuth T; Wilson J; Slattery C; Panoskaltsis-Mortari A; Gregersen PK; Behrens TW; Baechler EC
Arthritis Rheum; 2009 Oct; 60(10):3098-107. PubMed ID: 19790071
[TBL] [Abstract][Full Text] [Related]
7. CCL21 and IP-10 as blood biomarkers for pulmonary involvement in systemic lupus erythematosus patients.
Odler B; Bikov A; Streizig J; Balogh C; Kiss E; Vincze K; Barta I; Horváth I; Müller V
Lupus; 2017 May; 26(6):572-579. PubMed ID: 27614982
[TBL] [Abstract][Full Text] [Related]
8. Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus.
Dominguez-Gutierrez PR; Ceribelli A; Satoh M; Sobel ES; Reeves WH; Chan EK
Arthritis Res Ther; 2014 Jan; 16(1):R20. PubMed ID: 24451065
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.
Potter SM; Dwyer RM; Curran CE; Hennessy E; Harrington KA; Griffin DG; Kerin MJ
Breast Cancer Res Treat; 2009 May; 115(2):279-87. PubMed ID: 18521742
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
11. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma.
Kato M; Yamada Y; Maruyama K; Hayashi Y
Int Arch Allergy Immunol; 2010; 152 Suppl 1():62-6. PubMed ID: 20523065
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
Narumi S; Takeuchi T; Kobayashi Y; Konishi K
Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
[TBL] [Abstract][Full Text] [Related]
13. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
[TBL] [Abstract][Full Text] [Related]
14. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
Fu Q; Chen X; Cui H; Guo Y; Chen J; Shen N; Bao C
Arthritis Res Ther; 2008; 10(5):R112. PubMed ID: 18793417
[TBL] [Abstract][Full Text] [Related]
15. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
Choe JY; Kim SK
Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.
Willis R; Seif AM; McGwin G; Martinez-Martinez LA; González EB; Dang N; Papalardo E; Liu J; Vilá LM; Reveille JD; Alarcón GS; Pierangeli SS
Lupus; 2012 Jul; 21(8):830-5. PubMed ID: 22343096
[TBL] [Abstract][Full Text] [Related]
17. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
18. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
19. [Multiple types of chemokines expressed in mouse thymic stromal cell lines].
Xie L; Guo J; Qian X; Chen W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):498-501. PubMed ID: 12903388
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus.
Björkander S; Bremme K; Persson JO; van Vollenhoven RF; Sverremark-Ekström E; Holmlund U
Cytokine; 2012 Aug; 59(2):392-9. PubMed ID: 22633082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
